Abeona therapeutics to participate in the cantor fitzgerald cell and genetic medicines conference

New york and cleveland, sept. 13, 2022 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo) today announced that vish seshadri, chief executive officer of abeona, will participate in a panel discussion at the cantor fitzgerald cell and genetic medicines conference on thursday, september 15, 2022. the panel discussion, entitled, “late stage and commercial gene & cell therapy warriors: how they got to/crossed the finish line,” is scheduled to begin at 2:30 p.m. et. the company will also participate in one-on-one investor meetings at the conference.
ABEO Ratings Summary
ABEO Quant Ranking